Bionano Genomics Inc (NAS:BNGO)
$ 0.904 -0.026 (-2.8%) Market Cap: 62.47 Mil Enterprise Value: 49.37 Mil PE Ratio: 0 PB Ratio: 0.63 GF Score: 44/100

Q1 2020 Bionano Genomics Inc Earnings Call Transcript

Jun 18, 2020 / 08:30PM GMT
Release Date Price: $5.21 (+2.58%)
Operator

Greetings, and welcome to Bionano Genomics First Quarter 2020 Conference Call. (Operator Instructions) As a reminder, this conference is being recorded.

It is now my pleasure to introduce Monique Kosse. Please go ahead.

Monique Kosse
LifeSci Advisors, LLC - MD

Thank you, operator, and good afternoon, everyone. Welcome to the Bionano Genomics First Quarter Financial Results Conference Call. Leading the call today will be Dr. Erik Holmlin, CEO of Bionano.

After the market closed today, Bionano issued a press release announcing its financial results for the first quarter 2020. A copy of the release can be found on the Investor Relations page of the company's website.

Before we begin, I would like to remind everyone that certain statements made during this conference call may be forward-looking, including statements about our strategic and commercialization plans, 2020 sales pipeline, anticipated benefits or improvements to the Saphyr system, the advantages of the Saphyr system over current technologies, our expectations regarding

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot